A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE3
24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
- Status
- WITHDRAWN
- Phase
- PHASE4
Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
- Status
- COMPLETED
- Phase
- PHASE1
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1
SCHEDULE Follow Up Visit 5-7 yr
- Status
- COMPLETED
- Phase
- PHASE4
A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
- Status
- COMPLETED
- Phase
- PHASE4
A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
- Status
- COMPLETED
- Phase
- NA
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo
- Status
- COMPLETED
- Phase
- PHASE4